Review Article
Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors
Table 1
Carotenoid content of various preparations as announced in the commercial advertisement (but not verified).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A: astaxanthin; B: beta-carotene; C: crocin; L: lutein; M: meso-zeaxanthin; Z: zeaxanthin. Unless otherwise indicated, amounts are in mg. |